1. Home
  2. PCRX vs CCRN Comparison

PCRX vs CCRN Comparison

Compare PCRX & CCRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

HOLD

Current Price

$24.06

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo Cross Country Healthcare Inc. $0.0001 Par Value

CCRN

Cross Country Healthcare Inc. $0.0001 Par Value

HOLD

Current Price

$8.00

Market Cap

447.2M

ML Signal

HOLD

Company Overview

Basic Information
Metric
PCRX
CCRN
Founded
2006
1986
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Professional Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
447.2M
IPO Year
2011
N/A

Fundamental Metrics

Financial Performance
Metric
PCRX
CCRN
Price
$24.06
$8.00
Analyst Decision
Strong Buy
Hold
Analyst Count
6
4
Target Price
$33.83
$17.91
AVG Volume (30 Days)
707.7K
1.1M
Earning Date
11-06-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.47
N/A
Revenue
$716,791,000.00
$1,127,472,000.00
Revenue This Year
$6.24
N/A
Revenue Next Year
$9.53
N/A
P/E Ratio
$51.12
N/A
Revenue Growth
3.14
N/A
52 Week Low
$18.17
$7.43
52 Week High
$27.64
$18.30

Technical Indicators

Market Signals
Indicator
PCRX
CCRN
Relative Strength Index (RSI) 55.94 25.05
Support Level $23.29 $7.43
Resistance Level $24.81 $11.33
Average True Range (ATR) 1.00 0.53
MACD 0.07 -0.31
Stochastic Oscillator 64.85 11.68

Price Performance

Historical Comparison
PCRX
CCRN

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

About CCRN Cross Country Healthcare Inc. $0.0001 Par Value

Cross Country Healthcare Inc is a provider of total talent management services, including strategic workforce solutions, contingent staffing, permanent placement and consultative services for healthcare customers. The company operates in two business segments: the nurse and allied staffing segment, which generates a vast majority of revenue, offers temporary and permanent placements of travel and local nurses and allied professionals, and other outsourcing services.: the Physician Staffing segment provides licensed practitioners across a broad array of specialties, as well as certified registered nurse anesthetists (CRNAs), nurse practitioners (NPs), and physician assistants (PAs) on temporary assignments. The company earns majority of its revenue from the United States.

Share on Social Networks: